{"id":"W4407753578","doi":"10.1038/s41433-025-03732-2","title":"Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally","year":2025,"lang":"en","type":"article","venue":"Eye","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"ASTER","funders":"University of California, Irvine; Research to Prevent Blindness","keywords":"Biosimilar; Aflibercept; Medicine; Bevacizumab; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005810823,0.0004018743,0.000380095,0.0007193794,0.0007896676,0.004357452,0.0004568072,0.003527506,0.01903253],"category_scores_gemma":[0.008006016,0.0001611753,0.0005261766,0.0006291638,0.001435562,0.004855094,0.001120006,0.00338395,0.006281649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00226418,"about_ca_system_score_gemma":0.005526562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002331737,"about_ca_topic_score_gemma":0.003447078,"domain_scores_codex":[0.9978819,0.0005591087,0.0001077653,0.0001869195,0.0008668147,0.0003973892],"domain_scores_gemma":[0.9943869,0.000722327,0.0009803011,0.0001809382,0.001714003,0.002015529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001704561,0.0003632545,0.003596428,0.0004646222,0.00005100967,0.0003532474,0.0001755531,0.0003812824,0.009927948,0.04263962,0.2702548,0.6700877],"study_design_scores_gemma":[0.0003729957,0.00128649,0.00344061,0.0007381521,0.00006315348,0.0005355747,0.0005151181,0.0004968785,0.005813529,0.02104107,0.9656445,0.00005195389],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.03958779,0.09391737,0.007665716,0.6840206,0.03125081,0.0002510703,0.001232205,0.000640947,0.1414336],"genre_scores_gemma":[0.4274785,0.08601573,0.02493366,0.333576,0.02322208,0.0002589308,0.002104484,0.0004450811,0.1019655],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01903253,"threshold_uncertainty_score":0.06367016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01368515434072401,"score_gpt":0.2964538727724531,"score_spread":0.282768718431729,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}